Reassessing the Potential of Myb-targeted Anti-cancer Therapy
Authors:
Open Access
- 1 January 2018
- journal article
- review article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 9 (7) , 1259-1266
Abstract
Transcription factor MYB is essential for the tumorigenesis of multiple cancers, especially leukemia, breast cancer, colon cancer, adenoid cystic carcinoma and brain cancer. Thus, MYB has been regarded as an attractive target for tumor therapy. However, pioneer studies of antisense oligodeoxynucleotides against MYB, which were launched three decades ago in leukemia therapy, were discontinued because of their unsatisfactory clinical outcomes. In recent years, the roles of MYB in tumor transformation have become increasingly clear. Moreover, the regulatory mechanisms of MYB, such as the vital effects of MYB co-regulators on MYB activity and of transcriptional elongation on MYB expression, have been unveiled. These observations have underpinned novel approaches in inhibiting MYB. This review discusses the structure, function and regulation of MYB, focusing on recent insights into MYB-associated oncogenesis and how MYB-targeted therapeutics can be explored. Additionally, the main MYB-targeted therapies, including novel genetic therapy, RNA interference, microRNAs and low-molecular-weight compounds, which are especially promising inhibitors that target MYB co-regulators and transcriptional elongation, are described, and their prospects are assessed.Keywords
This publication has 73 references indexed in Scilit:
- Estrogen receptor-α recruits P-TEFb to overcome transcriptional pausing in intron 1 of the MYB geneNucleic Acids Research, 2012
- Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemiaNature Chemical Biology, 2012
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiaNature, 2011
- Hierarchical Maintenance of MLL Myeloid Leukemia Stem Cells Employs a Transcriptional Program Shared with Embryonic Rather Than Adult Stem CellsCell Stem Cell, 2009
- c-Myb is required for progenitor cell homeostasis in colonic cryptsProceedings of the National Academy of Sciences, 2007
- Mutations in the MYB intron I regulatory sequence increase transcription in colon cancersGenes, Chromosomes and Cancer, 2006
- The myb gene family in cell growth, differentiation and apoptosisOncogene, 1999
- Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell linesOncogene, 1997
- Viral myb oncogene encodes a sequence-specific DNA-binding activityNature, 1988